Alterations of circulating innate lymphoid cells in recent‐onset type 1 diabetes

Documenti analoghi

• Engineered iPSC ‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapy
  di: Jane Sun, et al.
  Pubblicazione: (2025)
• Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients
  di: Daming Cai, et al.
  Pubblicazione: (2024)
• Long‐lasting changes in circulating dendritic cell and monocyte subsets, and altered expression of EMR2, CD97 and EMR3 on these cells in the posttraumatic course
  di: Leyu Zheng, et al.
  Pubblicazione: (2025)
• Elevated high‐density lipoprotein levels following acute graft‐versus‐host disease onset: a potential link to T‐cell dysfunction and increased relapse risk
  di: Romy Böttcher‐Loschinski, et al.
  Pubblicazione: (2025)
• Dissecting infant and maternal antibody repertoires exposes the early onset of infant humoral immunity
  di: Albert Bondt, et al.
  Pubblicazione: (2026)